Specific collagen peptide compositions with new targeted health benefits
Did you know that collagen has unknown benefits?
Rousselot is decoding the collagen language for new targeted health benefits.
NEXTIDA™ is an innovative platform of specific collagen peptide compositions that act as a GPS guiding the body back to balance, naturally.
Read more in the blog.
Nextida.GC will be the first commercialized collagen peptides from the Nextida platform
Nextida.GC aims to reduce the post-meal blood sugar spike. Pre-clinical studies have demonstrated the incretin effect in which GLP1 plays a crucial role.
NEXTIDA: Unique and differentiated solution with unrivaled features
Don’t miss out on the latest information regarding the Nextida range.
Learn more about Nextida below:
Watch Nextida video
Get up to speed in a 60-second clip about Nextida’s specific collagen peptide compositions.
Watch here!Be the first to know!
Sign up to the Nextida newsletter and be the first to learn about the Nextida.GC study result.
I want to be informed!Nextida Webinar
Watch our on-demand Nextida Webinar to hear the ins & outs of this innovative platform with Elke De Clerck, PhD.
Watch now!Ask our experts for more information.
Disclaimer
Rousselot makes no representation or warranty, whether expressed or implied, as to the accuracy, reliability, or completeness of the information, nor does it assume any legal liability, whether direct or indirect, for any information. Use of this information shall be at your discretion and risk. Nothing herein relieves you from carrying out your own suitability determinations and tests and from your obligation to comply with all applicable laws and regulations and to observe all third party rights. This product is not intended to diagnose, treat, cure, or prevent any disease.